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Africaa b s t r a c t
Background: The laboratory has always played a very critical role in diagnosis of the diseases. The success
of any disease programme is based on a functional laboratory network. Health laboratory services are an
integral component of the health system. Efficiency and effectiveness of both clinical and public health
functions including surveillance, diagnosis, prevention, treatment, research and health promotion are
influenced by reliable laboratory services. The establishment of the African Regional polio laboratory
for the Polio Eradication Initiative (PEI) has contributed in supporting countries in their efforts to
strengthen laboratory capacity. On the eve of the closing of the program, we have shown through this
article, examples of this contribution in two countries of the African region: Côte d’Ivoire and the
Democratic Republic of Congo.
Methods: Descriptive studies were carried out in Côte d’Ivoire (RCI) and Democratic Republic of Congo
(DRC) from October to December 2014. Questionnaires and self-administered and in-depth interviews
and group discussions as well as records and observation were used to collect information during
laboratory visits and assessments.
Results: The PEI financial support allows to maintain the majority of the 14 (DRC) and 12 (RCI) staff
involved in the polio laboratory as full or in part time members. Through laboratory technical staff
training supported by the PEI, skills and knowledge were gained to reinforce laboratories capacity and
performance in quality laboratory functioning, processes and techniques such as cell culture. In the same
way, infrastructure was improved and equipment provided. General laboratory quality standards,
including the entire laboratory key elements was improved through the PEI accreditation process.
Conclusion: The Polio Eradication Initiative (PEI) is a good example of contribution in strengthening
public health laboratories systems in the African region. It has established strong Polio Laboratory
network that contributed to the strengthening of capacities and its expansion to surveillance of other
viral priority diseases such as measles, yellow fever, Influenza, MERS-CoV and Ebola.
This could serve as lesson and good example of laboratory based surveillance to improving diseases
prevention, detection and control in our middle and low income countries as WHO and partners are
heading to polio eradication in the world.
 2016 Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creative-
commons.org/licenses/by/3.0/).1. Introduction
The World Health Organization (WHO) African Region bears the
highest burden of communicable diseases including vaccine pre-
ventable diseases and non-communicable diseases [1]. Since1994, several laboratory networks have been established in the
African Region as part of immunization programmes. These include
polio, measles, and yellow fever. In some countries, these networks
utilize the same infrastructure and human resources.
The laboratory network established in the African Region for the
Polio Eradication Initiative (PEI) is composed of national and regio-
nal reference laboratories (Fig. 1). This network has supported PEI
by effectively confirming outbreaks of the different types of strains
Fig. 1. Map of laboratories in Africa.
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availability of resources, such as laboratory quality standards and
the availability of skilled staff.
The WHO global polio laboratory network is the largest public
health laboratory network ever created. The African Regional Polio
Laboratory Network forms part of this network and consists of
three Regional Reference Laboratories (RRLs) based in Central
African Republic, Ghana, and South Africa. In addition, 13 Intraty-
pic Differentiation (ITD) laboratories are responsible for isolation
of polioviruses from faecal samples using standardized procedures
and reagents, molecular characterization of isolates and referral of
critical isolates to a sequencing laboratory. In the African region,
the RRLs in South Africa and in Ghana also provide genetic
sequencing services to the African polio lab network.
The polio laboratory network is also in charge of reporting
results to stakeholders in coordination with the PEI programme
for further case investigations and poliovirus containment
activities. As of January 2016, the most recent result to note is
the eradication of the poliovirus type 2 in September 2015 [2].
The performance of these laboratories are regularly monitored
and documented through WHO annual accreditation exercises
and showed several successes in the current achievement.
The measles and yellow fever laboratory network has been built
on a similar platform as the polio lab network and is currently
made up of 37 Laboratories including RRLs based at Institut Pasteur
de Côte d’Ivoire in Côte d’Ivoire, Uganda Virus Research Institute in
Uganda, Institut Pasteur de Dakar in Senegal, and National Institute
of Communicable Diseases (NICD) in South Africa. Cote d’Ivoire,Uganda and NICD laboratories cover regional functions for measles
while Senegal laboratory covers regional functions for yellow fever.
Because most of the measles elimination programs in the WHO
African Region have moved to case based surveillance (which
requires laboratory confirmation of all cases), laboratory support
has become critical in assessing program progress.
The laboratory is indispensable for infectious diseases diagno-
sis, required for confirmation and is an important component of
surveillance and response in line with existing and new frame-
works such as the Integrated Disease Surveillance and Response
(IDSR), the International Health Regulations (IHR 2005), the One
Health approach and the Global Health Security Agenda (GHSA).
In the WHO African Region, despite the progress made during
the recent years for investigation and response to epidemic prone
diseases, laboratory services and systems are in general not fully
efficient in supporting disease surveillance and control. Laborato-
ries show weaknesses regarding the overall organization, qualified
human resources, sustained financial support and required
infrastructures and materials as well as compliance with quality
assurance management and biosafety and security measures [3].
Safety in the laboratory is a concern for laboratory staff and is
still a responsibility of the network to address such issues through
various training and education to promote risk assessment and
good laboratory safe practices. This will involve the reasonable
safety handling of the laboratory equipment [4]. In such a context
of weak national laboratory systems, the Poliomyelitis eradication
programmewhich has established strong Polio Laboratory network
contributed by the same way to the strengthening of capacities and
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measles, yellow fever, influenza, MERS-CoV and Ebola. These
disease control programmes and other initiatives or programmes
have partially benefited from PEI in term of infrastructure, staff
capacity building, equipment, logistics, and financing. However,
this statement is not yet fully documented by the WHO Regional
Office for Africa (AFRO).
The purpose of this publication is to give a feedback of the
laboratory best practice that was developed as part of PEI in two
countries namely, Côte d’Ivoire and DRC. The overview
demonstrates how the platform of the polio laboratory network
was used to strengthen the laboratory based-surveillance of other
diseases such as measles and yellow fever in these two countries
through infrastructure and trainings. These best practices are to
improve laboratory system and integration of laboratory services
as well as networking of regional public health laboratories as a
part of PEI legacy planning.Fig. 2. Training of polio laboratories.
Table 1
Accreditation criteria for virus isolation and intratypic differentiation (ITD).
1 Tests are performed on at least 150 stool specimens annually:
2 Results are reported on at least 80% of all AFP specimens within
14 days:
3 At least 80% of suspected poliovirus isolates from AFP cases and
contacts are forwarded for ITD within 7 days, if applicable:
4 Accuracy of identification of polioviruses among all isolates obtained
in L20B cells is at least 90%:
5 Score on most recent virus isolation PT is at least 90%:
6 Score on annual on-site review is at least 80%:
7 ITD test results on P80% of poliovirus isolates are reported within
7 days:
8 Non-Sabin-like poliovirus and ITD-discordant isolates fromP80% of
AFP cases, contacts and other sources are referred for sequencing
within 7 days of detection, if applicable:
9 Score on most recent intratypic differentiation PT is at least 90%:
Score for rRT-PCR ITD:
Score for rRT-PCR VDPV screening:
10 Accuracy of poliovirus serotype and intratype is at least 90%:
11 Score on annual on-site review is at least 90%:
12 Annual NPEV isolation rate is:2. Methods
As part of documentation of PEI best practices in the African
region in selected countries descriptive studies were carried out
in Côte d’Ivoire and Democratic Republic of Congo (DRC) from
October to December 2014. The studies used two standardized
electronic questionnaires and self-administered and in-depth
interviews and group discussions as well as on examination of doc-
uments and observation during laboratory visits and assessments.
The first was to collect detailed information on best practices and
the second questionnaire to collect information on the contribu-
tion or impact of the resources acquired for the eradication of polio
on the laboratory infrastructures, functioning, services, equipment
and staff.
Both laboratories have undergone trainings organized by the
regional office on different methods to determine poliovirus (PV)
serotypes and whether the virus was wild or related to vaccine
strains (known as intratypic differentiation or ITD) [5–11]. Any
wild poliovirus is further characterized to determine if it is an
importation or indigenous virus [12,13].
2.1. Trainings
African Polio Lab network has made changes to the laboratory
diagnostics protocols and this has improved laboratory perfor-
mance and reduced the result turnaround time dramatically. These
changes have necessitated the need to strengthen the laboratory
quality control and quality assurance systems through the imple-
mentation of quality cell culture techniques including cell sensitiv-
ity testing, cell validation and calibration trainings. In 2014, a
refresher course was organized to strengthen and sustain the nec-
essary support to the Polio Eradication Programme and to provide
practical orientation on how to maintain cells and monitor their
sensitivity. The objectives was to provide practical orientation to
participants on the mechanisms of cell culture propagation, train
participants on making their own house reference standards and
train them on their technical orientation on monitoring cell sensi-
tivity (Fig. 2).
2.2. Technical support and accreditation visits
The purpose is to conduct an on-site review of the performance
of the polio laboratory at the Institut for the last 12 months to
check if the laboratory still meets the requiredWHO recommended
standards.
Accreditation process is used to measure if the laboratory has
the capability and the capacity to detect, identify, and promptlyreport wild polioviruses, vaccine derived polioviruses (VDPV) and
Sabin viruses that may be present in clinical and environmental
specimens. This process further provides a mechanism for identify-
ing resource and training needs of the laboratory staff. It also a
measure of progress made by laboratories in order to meet WHO
set criteria for all WHO Global Polio Laboratory Network (GPLN).
The 11 criteria set by WHO are as stated in Table 1 for different
assays as stated in the checklists [14].3. Results
The DRC is one of the largest (2.35 million square kilometers)
and most populous (approximately 75 million inhabitants)
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tries, two borders (with Angola in the south and the Republic of
Congo [Congo] in the west) extend >2000 km. The DRC is adminis-
tratively divided in 11 provinces (including the city-province of
Kinshasa); each province is further divided into districts. The pub-
lic health system is organized in 515 health districts (Zones de
Santé). The national polio laboratory of the Democratic Republic
of the Congo is hosted since its operation by the National Institute
of Biomedical Research (INRB).
Côte d’Ivoire is a West African country on the Atlantic coast, is
the country’s major urban center. The estimated total population
is approximately 20.3 million. The country is divided into 31
regions with Abidjan having the highest population.
The poliomyelitis eradication programme has contributed to
the establishment and strengthening of capacities of the Polio Lab-
oratory in several domains of laboratory, as well as key elements as
quality standards or process aspects. That allows its expansion to
surveillance of other diseases. The most important contribution
to laboratory capacity and system strengthening are as follows.3.1. Human resources
Like in all programmes, human resource crisis is a limiting lab-
oratory services at all levels of the health systems.
The INRB has 14 staff members comprising of a Director, 3 biol-
ogists, 8 technicians and 1 logistician. All members are fully
involved will the Polio laboratory activities, however there is a
cross cutting activities such as measles and yellow fever. These
staff members are fully supported financially by the polio
programme.
The Reference Laboratory for Polio, located in Pasteur Institute
Côte d’Ivoire has 12 staff composed 03 doctors and 6 technicians,
2 engineers and 1 logistician. The majority of the staff is involved
in the polio laboratory as full or in part time members. The polio
work is fully financial supported by WHO and some staff are paid
by WHO.
The funding support that the regional office implemented to
these two laboratories has decreased a staff turnover by closed
100% which previously had caused a serious paralysed system
within the network as staff members had to leave the polio work
and look for better paying positions elsewhere.3.2. Trainings
The National laboratories are responsible for isolation of polio-
viruses from faecal samples using standardized procedures and
reagents, referral of suspected poliovirus isolates to the Regional
Reference Laboratories, reporting results to stake holders, coordi-
nation with the Programme in case investigations and poliovirus
containment activities. The Regional Reference Laboratories and
ITD laboratories serve as Polio National Laboratories to their own
countries and to other specified countries that do not have
National Laboratories. They also perform intratypic differentiation
on suspected poliovirus isolates to classify them into wild or Sabin
viruses. In the case of the South African laboratory it also provides
genetic sequencing services to the African laboratory network.
Based on the annual trainings organized by the regional office, both
laboratories have maintained a stable laboratory performance that
is above target of all laboratory performance indicators.
The eradication of poliomyelitis will be accomplished only
when these laboratories provide convincing diagnostic evidence
of the absence of wild poliovirus infections in humans and circula-
tion in the environment. In addition, because these laboratories
store specimens from acute flaccid paralysis (AFP) cases and wild
polioviruses isolates, containment of these materials and virusesremains one of the laboratories responsibilities that are a pre-
requisite for certifying Africa free of polio.
The above functions require that the network laboratories are
efficiently coordinated in order to ensure the desired quality per-
formance. This quality performance is made possible through the
implementation of quality control and quality assurance systems.
3.3. Infrastructure
A new procedure adopted by the polio laboratory for poliovirus
isolation and identification as per the new standard WHO algo-
rithm of testing provides results of primary isolation within
14 days of receipt of sample in the laboratory. Also results of char-
acterization as a wild type, VPDV or vaccine strain of polioviruses
by an intratypic differentiation (ITD) testing procedure should be
available within seven days.
In August 2008, the Global Polio Working Group has approved
the RT-PCR technique developed by the United States Centers for
Disease Control and Prevention (CDC) for implementation in the
Global Polio Laboratory Network (GPLN) to differentiate the wild,
VDPV and vaccine poliovirus strains.
In 2010, the new technique was adopted and implemented in
the African region. Based on the agreement to adopt real time
PCR for ITD laboratories, there was a need of procuring the real
time machine as the majority of the laboratories were not molec-
ular laboratories. The GPLN procure 16 machines for each labora-
tory in the African region, and DRC and Côte d’Ivoire laboratories
were part of the beneficiaries for this new change.
3.4. Technical support
A hands-on training was planned to introduce the newly devel-
oped real time PCR technique for rapid detection of wild type,
VDPV and vaccine poliovirus strains. Participants were trained
for laboratory procedures and work practices in confirmation of
poliovirus using the new real time PCR techniques for ITD and
VDPV screening. With the introduction of this technique, the time
and cost in performing sequencing to detect VDPV was reduced.
In 2014 a technical visit was conducted by WHO in the Institut
Pasteur de Cote d’Ivoire Polio Laboratory to assess the laboratory
performance based on the low indicators of non-polio enterovirus
isolation rate. The findings revealed that some existing standard
operation procedures need to be developed and some to be
updated. It was noted that some equipment need to be procured
based on the amount of work handled by the laboratory. There
was a need of follow-up regarding the maintenance of some equip-
ment as they were no records available during the time of the visit.
3.5. Accreditation visits
The National Polio Laboratory (NPL) of Côte d’Ivoire is hosted by
the Institut Pasteur de Côte d’Ivoire in Abidjan. Its activity includes
the acute flaccid paralysis (AFP) surveillance of five countries
namely; Côte d’Ivoire, Burkina-Faso, Mali, Liberia and Sierra Leone.
The NPL performs viral isolation and ITD and uses the ITD method-
ology of real-time polymerase chain reaction technique (rRT-PCR).
The number of stool specimens received during the recent
accreditation visit was 1853. Following the Ebola Epidemics, for
biosafety reasons, stool specimen of Liberia and Sierra-Leone were
not received from July 2014.
Staffs are competent and the number is adequate for the current
workload. NPL activities are perfectly traceable and documentation
of records and archives is available. Job descriptions mentioning
tasks and responsibilities of each staff are available. Work assign-
ments in a weekly work plan are however recommended. Training
courses for two technical staffs are also recommended.
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regard to viral isolation and ITD activities. Scores of proficiency
testing for virus isolation and ITD are satisfactory. Score on on-
site review of laboratory procedures and methodologies are met.
Timeliness of reporting virus isolation and ITD results, timeliness
of referral of isolates for sequencing, accuracy of L20B positives
serotype and intratypic identification are adequate.
The National Polio Laboratory (NPL) of the Democratic Republic
of the Congo is hosted since its operation by the National Institute
of Biomedical Research (INRB). During last accreditation visit, the
laboratory has received and tested 3977 faecal samples from AFP
cases; no wild poliovirus identified of these samples. Performance
indicators showed (i) a good timeliness of rendering the results of
virus isolation and intratypic differentiation (ITD), (ii) a rapid
transfer of the isolates with results of said discordant to the labo-
ratory in charge of sequencing, (iii) to excellent scores on the Pro-
ficiency Test virus isolation and ITD, and (iv) a good concordance of
the results with those received from the sequencing laboratory.
The main weaknesses of the laboratory reside in - infrastruc-
ture: problem of supply electricity dimensions of the rooms and
corridors by non-functional equipment - safety/security: wiring
and operation of the network (mains vs generator) pose a serious
safety concern for the staff and the laboratory. Biosecurity: the
hood biological safety used for the treatment of samples is more
functional and the viral isolation room does not autoclave. The lack
of maintenance and calibration of equipment.
3.6. Contribution to the improvement of Laboratory key elements
The poliomyelitis reference laboratory (Institut Pasteur of Côte
d’Ivoire (IPCI) in Côte d’Ivoire and Institut National de Recherché
Biologique (INRB) inDRC)werepartially used for diagnosis activities
of other diseases, mainly vaccine preventable diseases such Yellow
fever, Measles, Influenza, Rubella, Ebola, seroprevalence studies
(Hemorrhagic fevers - Rabies - Herpes - Measles, Influenza). The
two reference laboratories are also sub-regional reference laborato-
ries for other countries. They offer biological diagnosis using meth-
ods such as cell culture and pathogens characterization and
equipment which are used for the implementation of other public
health programmes (e.g. Measles, Yellow Fever, and Influenza).
Infrastructure was improved, making the laboratory space and
commodities adequate for the work conditions and concordant
with biosafety and security requirements. This also improved the
workload and thus allowed satisfactory conditions for staff. A virol-
ogy laboratory was installed at the IPCI (to be extended), and new
and adapted equipment was acquired (to be detailed in a table
together with equipment gained in DRC). Those facilities were used
by the units implementing other public health programmes. PEI
dedicated staff also perform diagnosis activities of other priority
diseases under surveillance as indicated in Table 1.
3.7. Contribution to the improvement of Laboratory quality standards
Accreditation provides documentation that the laboratory has
the capability and the capacity to detect, identify, and promptlyTable 2
Time polio laboratory staff spent on other programmes in Côte d’Ivoire and Democratic R
Côte d’Ivoire
Function Number of staff Mean percentage of time spent on
managing other pathogens (%)
Lab head 1 20
Biologist 1 50
Data manager 1 50
Technicians 6 48.8report wild polioviruses, vaccine derived polioviruses (VDPV) and
Sabin viruses that may be present in clinical and environmental
specimens. The accreditation process further provides a learning
opportunity, a mechanism for identifying resource and training
needs, a measure of progress, and a link to the WHO Global Polio
Laboratory Network (GPLN).
Accreditation of laboratories is reviewed annually by the WHO
Regional Office and is based on laboratory performance during the
immediately preceding 12 months with complete data and accred-
itation is given for the upcoming period of 12 months.
Institut National de Recherché Biologique (INRB) was accredited
as a WHO national reference laboratory in 2000 and has facilitated
disease surveillance and control in the DRC and other countries
such as Republic of Congo. In the same note Institut Pasteur of
Côte d’Ivoire (IPCI) in Côte d’Ivoire is a fully WHO accredited
national reference laboratory servicing Burkina Faso, Côte d’Ivoire,
Mali, Liberia and Sierra Leone. For the past years both laboratories
have been fully accredited to serve as the national laboratories for
the countries mentioned above.
In addition to accreditation, laboratories are expected to partic-
ipate in the external proficiency scheme provided by Centers for
Disease Control and Prevention (CDC), Atlanta and Rijksinstituut
voor Volksgezondheid en Milieu (RIVM), Netherlands. Both labora-
tories have performing very well in the past exercises by reaching
the above passing marks and were deemed competent to remain in
the regional polio network.
3.8. Contribution to the improvement of Laboratory functioning and
processes
Polio networks used to support safely collection and timely
transportation of specimens (personnel, costs, transportation
means)
Equipment maintenance costs and other financial contributions
from the Polio laboratory help to reduce the financial burden of the
institutions hosting the laboratory.
Full time and half time staff paid by the PEI also work on other
diseases. Incentive allowance paid to ‘‘polio staff” and the incen-
tives granted to ‘‘polio staff” also go to some measles-yellow fever
laboratory workers.
Surveillance and monitoring and evaluation of Yellow Fever,
Measles and Influenza control programmes were strengthened as
they were partially taken into account by the PEI laboratory net-
work. Using the same polio network platform, introduction of
new vaccines such Rota, meningitis, Hepatitis benefited as the
same molecular techniques implemented for polio is in used of
the other programmes such the ones mentioned before (Table 2).
4. Discussion
The laboratory staff members in the African region of whom
many are working in insecure or very challenging have shown
commitment and dedication. They also had been at the center of
strengthening immunization. The polio network has been used to
strengthen integrated disease surveillance and response (IDSR) inepublic of Congo.
Democratic Republic of Congo
Function Number of staff Mean percentage of time spent on
managing other pathogens (%)
Director 1 70
Biologist 4 25
Data manager 1 25
Technicians 8 25
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tion and control of other vaccine preventable diseases such as par-
ticularly yellow fever and measles. The same staff members have
been involved with the epidemiological and virological surveil-
lance of influenza as well as response to other major public health
threats including the Ebola virus and Marburg virus outbreaks. The
valuable technical support that they are providing to the national
authorities and other stake-holders is a major contributory factor
to the progress that the polio network continues to register.
Both laboratories have contributed tremendously to the polio
eradication programme in providing reliable and timely results
for the PEI programme to act on outbreak response should a wild
poliovirus or vaccine derived poliovirus is reported.
However, apart from the excellent contribution of the polio net-
work to immunization, there is still a big gap in meeting the needs
of other vaccine preventable diseases programmes. Funding still
creates a separation between polio and other VPD programme
and causes some divisions in other laboratories.
The lesson learnt by other programme from polio surveillance
had helped to maintain a stable surveillance system for other
programmes. Collection, storage and transportation of stool sam-
ples within a set turnaround time, has taught other programmes
to maintain similar process in adequate shipment of infectious
substances within and outside the country.
The polio laboratory network is the system that manages the
processes and standards required to produce accurate reliable and
timely results. The implementation of new techniques as it was
the case needed dedicated and motivated staff, good quality man-
agement systems, safe environment, adequate infrastructure and
a good supervisory role. The WHO funds spent on PEI has helped
in investing in people, infrastructure and system successfully.
Using the same infrastructure, this can improve and strength-
ened other disease surveillance systems, laboratory networks and
monitoring and evaluation other diseases. The support will be in
the form of technical guidance, effective quality assurance, systems
and capacity building are all-attainable. After the eradication of
poliovirus, a new focus on other diseases in terms of strengthening
laboratory systems for quality assurance as itwas learned frompolio
programme will help achieve the target for surveillance and
response to priority diseases including any disease elimination or
eradication.
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